Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alector
Biotech
GSK cuts losses on $700M upfront Alzheimer’s collab with Alector
GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs involved flunk clinical trials.
James Waldron
Jul 9, 2026 7:30am
GSK’s $700M Alector bet blows up with 2nd Alzheimer’s fail
Apr 30, 2026 5:15am
Alector halves staff after GSK-partnered antibody fails in ph. 3
Oct 22, 2025 11:23am
Alector lays off 17% of staff after ph. 2 Alzheimer's drug fail
Nov 26, 2024 4:50am
AbbVie dumps Alector's Alzheimer's immunotherapy after phase 1
Jul 8, 2022 6:04am
With GSK, Alector to capitalize on big moment in Alzheimer's
Jan 27, 2022 9:35am
